El Salvador’s bitcoin adoption ‘may come at a high cost’
Raffaele Redi •
EBS
EBS
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). Its products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. The company offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. It also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, the company offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, it offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, the company offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. Emergent BioSolutions Inc. has a development and manufacturing agreement with Novavax Inc. for coronavirus disease vaccine candidate. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.
White Paper Declaration
White Paper Declaration
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in
EBS price history
| Date | Close | Change | Change(%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 17, 2021 | 57.01 | 0.11 | 0.19% | 56.90 | 57.38 | 56.40 |
| Sep 16, 2021 | 57.37 | 0.62 | 1.09% | 56.75 | 57.80 | 56.45 |
| Sep 15, 2021 | 57.05 | 0.14 | 0.25% | 56.91 | 58.16 | 56.65 |
| Sep 14, 2021 | 57.11 | -0.12 | -0.21% | 57.23 | 57.65 | 56.47 |
| Sep 13, 2021 | 57.25 | 0.06 | 0.10% | 57.19 | 57.76 | 56.84 |
| Sep 10, 2021 | 56.95 | -1.20 | -2.06% | 58.15 | 58.51 | 56.68 |
| Sep 9, 2021 | 58.41 | -0.99 | -1.67% | 59.40 | 59.45 | 58.40 |
| Sep 8, 2021 | 59.73 | -0.51 | -0.85% | 60.24 | 60.95 | 59.65 |
| Sep 7, 2021 | 60.66 | -2.03 | -3.24% | 62.69 | 63.14 | 60.15 |
| Sep 3, 2021 | 63.04 | 0.30 | 0.48% | 62.74 | 63.26 | 62.03 |
| Sep 2, 2021 | 63.23 | 0.18 | 0.29% | 63.05 | 63.47 | 62.39 |
| Sep 1, 2021 | 63.50 | 0.80 | 1.28% | 62.70 | 63.92 | 62.30 |
| Aug 31, 2021 | 62.95 | -0.03 | -0.05% | 62.98 | 63.91 | 62.40 |
| Aug 30, 2021 | 63.67 | -0.43 | -0.67% | 64.10 | 64.94 | 63.59 |
| Aug 27, 2021 | 64.02 | 1.37 | 2.19% | 62.65 | 64.25 | 62.09 |
| Aug 26, 2021 | 62.72 | -1.17 | -1.83% | 63.89 | 64.60 | 62.57 |
| Aug 25, 2021 | 64.20 | 1.77 | 2.84% | 62.43 | 64.44 | 61.89 |
| Aug 24, 2021 | 62.65 | -0.52 | -0.82% | 63.17 | 63.51 | 62.19 |
| Aug 23, 2021 | 63.55 | 0.54 | 0.86% | 63.01 | 64.90 | 62.91 |
| Aug 20, 2021 | 63.12 | 2.67 | 4.42% | 60.45 | 63.32 | 60.45 |
